ES433961A1 - A METHOD FOR THE PURIFICATION AND CONCENTRATION OF UROQUINA-SA. - Google Patents

A METHOD FOR THE PURIFICATION AND CONCENTRATION OF UROQUINA-SA.

Info

Publication number
ES433961A1
ES433961A1 ES433961A ES433961A ES433961A1 ES 433961 A1 ES433961 A1 ES 433961A1 ES 433961 A ES433961 A ES 433961A ES 433961 A ES433961 A ES 433961A ES 433961 A1 ES433961 A1 ES 433961A1
Authority
ES
Spain
Prior art keywords
urokinase
solution
neutral
agaropectin
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES433961A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1002274A external-priority patent/JPS517751B2/ja
Priority claimed from JP1201674A external-priority patent/JPS517752B2/ja
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Publication of ES433961A1 publication Critical patent/ES433961A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Urokinase of a high degree of purity is obtained in good yield by adsorption of the urokinase from a contaminated aqueous urokinase solution, e.g. human urine, on an agaropectin-containing water-insoluble polysaccharide, e.g. agar or an agarose, and agaropectin-containing preparation. The polysaccharide is then removed at a weakly acidic to neutral pH, which is set, e.g., using a buffered salt solution, with the urokinase adsorbed thereon by ion formation. After washing out the impurities which may be present, the urokinase is eluted in an ion exchange reaction using an aqueous alkaline solution or a concentrated aqueous, neutral solution of a salt or a neutral amino acid. Purified urokinase is used clinically to a large extent for the therapy of peripheral arterial and venous thromboses and myocardial infarcts, which can be attributed to the formation of fibrin clots in blood vessels.
ES433961A 1974-01-22 1975-01-20 A METHOD FOR THE PURIFICATION AND CONCENTRATION OF UROQUINA-SA. Expired ES433961A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1002274A JPS517751B2 (en) 1974-01-22 1974-01-22
JP1201674A JPS517752B2 (en) 1974-01-28 1974-01-28

Publications (1)

Publication Number Publication Date
ES433961A1 true ES433961A1 (en) 1976-11-16

Family

ID=26345171

Family Applications (1)

Application Number Title Priority Date Filing Date
ES433961A Expired ES433961A1 (en) 1974-01-22 1975-01-20 A METHOD FOR THE PURIFICATION AND CONCENTRATION OF UROQUINA-SA.

Country Status (10)

Country Link
AT (1) AT341079B (en)
AU (1) AU474513B2 (en)
CA (1) CA1028262A (en)
CH (1) CH611314A5 (en)
DE (1) DE2502095C3 (en)
ES (1) ES433961A1 (en)
FR (1) FR2258396B1 (en)
GB (1) GB1476092A (en)
IN (1) IN139029B (en)
SE (1) SE434956B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444465A1 (en) * 1978-12-22 1980-07-18 Green Cross Corp PROCESS FOR PRODUCING THROMBOLYTIC PREPARATION

Also Published As

Publication number Publication date
DE2502095A1 (en) 1975-07-24
DE2502095C3 (en) 1979-02-22
GB1476092A (en) 1977-06-10
AU474513B2 (en) 1976-07-22
CH611314A5 (en) 1979-05-31
ATA43475A (en) 1977-05-15
FR2258396B1 (en) 1977-11-18
SE434956B (en) 1984-08-27
SE7500629L (en) 1975-07-23
AU7688374A (en) 1976-06-24
FR2258396A1 (en) 1975-08-18
DE2502095B2 (en) 1978-06-29
CA1028262A (en) 1978-03-21
IN139029B (en) 1976-04-24
AT341079B (en) 1978-01-25

Similar Documents

Publication Publication Date Title
IL64323A (en) Process for the production of hepatitis-safe blood-clotting factors ii and vii
DE1642660A1 (en) Process for the production of urokinase
CA1078732A (en) Process for the preparation of thrombinlike enzymes from snake venoms
US3943245A (en) Purification of plasminogen
JPS5944286B2 (en) Purification method of bovine thrombin
GB1401737A (en) Anti-coagulant isolation
US3808124A (en) Purification of human plasminogen
ATE111165T1 (en) HIGH-PERFORMANCE BIPOLAR MEMBRANES.
ES433961A1 (en) A METHOD FOR THE PURIFICATION AND CONCENTRATION OF UROQUINA-SA.
US4048014A (en) Method for obtaining urokinase
JPS5935B2 (en) Purification method of urokinase
GB1507215A (en) Processes for producing immunoregulatory preparations
FR2386555A1 (en) UROKINASE PURIFICATION PROCESS
PL85201B1 (en)
ES423697A1 (en) A PROCEDURE FOR PREPARING A HUMAN SERUM HAPTOGLOBIN SOLUTION.
JPS57150382A (en) Purification of super oxide dismutase
SU506619A1 (en) Method for isolation and purification of fibrinolytic drug
JPS57146580A (en) Separation and purification of enzyme in human urine
JPS5754121A (en) Production of substance having antiviral and carcinostatic activity
GB1411422A (en) Methods for purifying urokinase preparations
JPS5452788A (en) Purification of urokinase
JPS5599191A (en) Purification of kallikrein in human urine
JPS55150900A (en) Production of interferon
GB766992A (en) Improvements in or relating to the production of heparin
JPS56134987A (en) Separation and purification of choline oxidase and or betaine aldehyde dehydrogenase